INS and intestinal obstruction: Additionally, both studies compared GLP-1RAs with SGLT-2 inhibitors, but the risk of intestinal obstruction associated with GLP-1RAs compared to other commonly used anti-diabetic medications, including insulin and metformin, remains unknown.